Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
In workers’ compensation, catastrophic injuries transpire with relatively low frequency.
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
When adjusters have to jump through hoops to make referrals, they lose precious time.